ReviewAnnals of the New York Academy of Sciences2011

Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.

Priscilla A Furth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.